13-47954148-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003850.3(SUCLA2):​c.1099G>A​(p.Asp367Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00545 in 1,613,104 control chromosomes in the GnomAD database, including 404 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D367Y) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0094 ( 66 hom., cov: 32)
Exomes 𝑓: 0.0050 ( 338 hom. )

Consequence

SUCLA2
NM_003850.3 missense

Scores

3
7
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 7.51

Publications

5 publications found
Variant links:
Genes affected
SUCLA2 (HGNC:11448): (succinate-CoA ligase ADP-forming subunit beta) Succinyl-CoA synthetase (SCS) is a mitochondrial matrix enzyme that acts as a heterodimer, being composed of an invariant alpha subunit and a substrate-specific beta subunit. The protein encoded by this gene is an ATP-specific SCS beta subunit that dimerizes with the SCS alpha subunit to form SCS-A, an essential component of the tricarboxylic acid cycle. SCS-A hydrolyzes ATP to convert succinate to succinyl-CoA. Defects in this gene are a cause of myopathic mitochondrial DNA depletion syndrome. A pseudogene of this gene has been found on chromosome 6. [provided by RefSeq, Jul 2008]
SUCLA2 Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
    Inheritance: AR, Mitochondrial Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004880607).
BP6
Variant 13-47954148-C-T is Benign according to our data. Variant chr13-47954148-C-T is described in ClinVar as Benign. ClinVar VariationId is 139362.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0668 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003850.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SUCLA2
NM_003850.3
MANE Select
c.1099G>Ap.Asp367Asn
missense
Exon 8 of 11NP_003841.1E5KS60

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SUCLA2
ENST00000646932.1
MANE Select
c.1099G>Ap.Asp367Asn
missense
Exon 8 of 11ENSP00000494360.1Q9P2R7-1
SUCLA2
ENST00000643023.1
c.1162G>Ap.Asp388Asn
missense
Exon 9 of 12ENSP00000495664.1A0A2R8Y6Y7
SUCLA2
ENST00000853364.1
c.1156G>Ap.Asp386Asn
missense
Exon 9 of 12ENSP00000523423.1

Frequencies

GnomAD3 genomes
AF:
0.00936
AC:
1422
AN:
151948
Hom.:
62
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00237
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0695
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.0427
Gnomad SAS
AF:
0.00208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.0170
AC:
4253
AN:
250876
AF XY:
0.0131
show subpopulations
Gnomad AFR exome
AF:
0.00197
Gnomad AMR exome
AF:
0.0944
Gnomad ASJ exome
AF:
0.00119
Gnomad EAS exome
AF:
0.0460
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.0113
GnomAD4 exome
AF:
0.00503
AC:
7353
AN:
1461038
Hom.:
338
Cov.:
31
AF XY:
0.00455
AC XY:
3305
AN XY:
726818
show subpopulations
African (AFR)
AF:
0.00150
AC:
50
AN:
33436
American (AMR)
AF:
0.0957
AC:
4271
AN:
44632
Ashkenazi Jewish (ASJ)
AF:
0.00161
AC:
42
AN:
26116
East Asian (EAS)
AF:
0.0626
AC:
2483
AN:
39674
South Asian (SAS)
AF:
0.000986
AC:
85
AN:
86218
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53378
Middle Eastern (MID)
AF:
0.000521
AC:
3
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000810
AC:
90
AN:
1111482
Other (OTH)
AF:
0.00545
AC:
329
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
317
634
952
1269
1586
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00942
AC:
1432
AN:
152066
Hom.:
66
Cov.:
32
AF XY:
0.0106
AC XY:
791
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.00236
AC:
98
AN:
41496
American (AMR)
AF:
0.0703
AC:
1073
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3464
East Asian (EAS)
AF:
0.0424
AC:
220
AN:
5184
South Asian (SAS)
AF:
0.00187
AC:
9
AN:
4802
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10542
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
67986
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
66
131
197
262
328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00310
Hom.:
12
Bravo
AF:
0.0157
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.0132
AC:
1607
Asia WGS
AF:
0.0210
AC:
72
AN:
3478
EpiCase
AF:
0.0000546
EpiControl
AF:
0.000237

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
3
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria (3)
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.57
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.18
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.31
T
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.97
D
MetaRNN
Benign
0.0049
T
MetaSVM
Benign
-0.52
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
7.5
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-4.4
D
REVEL
Pathogenic
0.73
Sift
Benign
0.10
T
Sift4G
Benign
0.086
T
Polyphen
0.88
P
Vest4
0.28
MPC
0.62
ClinPred
0.033
T
GERP RS
5.5
Varity_R
0.49
gMVP
0.91
Mutation Taster
=16/84
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117412559; hg19: chr13-48528283; COSMIC: COSV66222679; COSMIC: COSV66222679; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.